Tag: closed system transfer devices market growth

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Closed System Transfer Devices Market Size From 2025 to 2034?

In recent times, the closed system transfer devices market has seen swift growth. The market, which is projected to expand from $1.04 billion in 2024 to $1.18 billion in 2025, boasts a compound annual growth rate (CAGR) of 13.7%. The historic growth can be credited to multiple factors such as the upswing in oncology drug approvals, the amplifying emphasis on occupational safety, the increased necessity to limit needlestick injuries and contact with toxic drugs, heightened awareness about the potential risks of cytotoxic drug exposure, and the growing population of chemotherapy patients.

Anticipated to experience accelerated expansion in the ensuing years, the market size for closed system transfer devices is projected to reach $1.96 billion by 2029, reflecting a compound annual growth rate (CAGR) of 13.4%. This projected growth during the forecast period can be linked to the rise in cancer rates, the growing necessity for observing regulations for the secure administration of harmful drugs, increased awareness surrounding the use of closed system transfer devices, and the upscaling use of CSTDS for the transport of hazardous drugs, along with the growing number of drug approvals for cancer. The forecast period also sees key trends such as the launch of new products, safety measures, creation of user-friendly devices and digital platforms, heightened research and developmental activities, technological advancements, and the preference for membrane-to-membrane systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Closed System Transfer Devices Market?

The surge in cancer incidences is anticipated to drive the expansion of the closed-system transfer devices market. Cancer, identified by the uncontrolled proliferation of abnormal cells which invade surrounding tissues and metastasize to other parts of the body through blood and lymph systems, is becoming increasingly common. This rise can be attributed to lifestyle factors, environmental exposures, and a higher rate of infections. Closed-system transfer devices play a crucial role in cancer therapy, as they safeguard healthcare workers and patients from the risks associated with handling and administering chemotherapy medications. Their application promotes a more secure healthcare environment and improved cancer patient treatment outcomes. For example, the World Health Organization, a Switzerland-based intergovernmental organization, highlighted in February 2024 that by 2050, it is expected that cancer cases will surpass 35 million, a hefty 77% upward surge from the estimated 20 million cases projected for 2022. This substantial increase underscores the escalating global burden of cancer. Furthermore, the National Center for Biotechnology Information, a US-based intergovernmental organization, stated in January 2023 that there were 1,958,310 new cancer cases in the United States and approximately 609,820 cancer deaths are projected to happen in 2023. Hence, the escalating crisis of cancer is fueling the growth of the closed system transfer devices market.

Which Key Market Segments Comprise the Closed System Transfer Devices Market and Drive Its Revenue Growth?

The closed system transfer devicesmarket covered in this report is segmented –

1) By Type: Needleless Systems, Membrane-To-Membrane Systems

2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

Subsegments:

1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

Which Areas Are Leading Regions in the Closed System Transfer Devices Market Expansion Across the Globe?

North America was the largest region in the closed system transfer device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Strategic Trends Steering theClosed System Transfer Devices Market Direction?

Leading corporations in the closed system transfer devices (CSTD) sector are prioritizing the advancement of innovative syringe units. This is aimed at boosting safety, enhancing the user experience, lowering contamination risk, and meeting rigorous healthcare industry regulations. A full-volume use syringe unit refers to a specially designed syringe for delivering or administering its entire medication or liquid contents without extra dilution or mixing. For instance, in October 2023, Equashield, an American medical device firm, introduced the EQUASHIELD Syringe Unit. This FDA-cleared unit for full-volume usage allows for safer and more effective management of hazardous drugs. Its cutting-edge design stops the escape of vapours and the contamination of the plunger, making it a cost-efficient solution for medication compounding and administration.

View the full report here:

https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

How Is the Closed System Transfer Devices Market Conceptually Defined?

Closed system transfer devices (CSTDs) are specialized drug transfer devices designed to mechanically prevent environmental contaminants from entering the system and to stop hazardous drugs or vapor concentrations from escaping. These devices create a closed, leak-proof system to ensure the safe handling of hazardous substances in healthcare environments.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15767

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Closed System Transfer Devices Market In 2029?

In recent times, the market size for closed system transfer devices has expanded swiftly. It is forecasted to increase from $1.04 billion in 2024 to $1.19 billion in 2025, with a compound annual growth rate (CAGR) of 14.5%. The historic period’s growth is tied to factors such as the upsurge in approvals for oncology drugs, amplified attention towards occupational safety, an accelerated need to limit needlestick injuries and contact with risky drugs, heightened awareness about the possible hazards associated with cytotoxic drug exposure, and an increase in the population of chemotherapy patients.

What Growth Rate Is Forecasted for the Closed System Transfer Devices Market by 2029?

The market size for closed system transfer devices is predicted to experience significant expansion in the upcoming years. It is projected to reach $2.03 billion in 2029, with a compounded annual growth rate (CAGR) of 14.3%. Factors contributing to this growth during the forecast period include a surge in cancer cases, the growing necessity to ensure safe management of harmful drugs, increased consciousness about the use of closed system transfer devices, and an increased utilization of CSTDS for the transportation of dangerous medications, along with a rise in the number of approved drugs for cancer. Key trends anticipated during the forecast period are the introduction of new products and safety measures, proliferation of digital platforms and devices that are easy to use, heightened research and development activities, technological progress, and the implementation of membrane-to-membrane systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

Which Key Companies Are Shaping the Future of the Closed System Transfer Devices Market?

Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., Corning Incorporated, B Braun Melsungen AG, Grifols SA, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Carmel Pharma AB, Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

Which Factors Are Driving Demand in the Closed System Transfer Devices Industry?

The surge in cancer cases is predicted to fuel the expansion of the closed-system transfer devices market. Characterized by unrestrained growth of abnormal cells, cancer can infiltrate adjacent tissues and metastasize to different body parts via the blood and lymphatic systems. With numerous factors like lifestyle patterns, environmental exposure, and heightened infections contributing to its increase, cancer cases are rising alarmingly. Closed-system transfer devices play a crucial role in cancer treatment, shielding healthcare professionals and patients from the risks associated with the management and operation of chemotherapy medication. Their utilization enhances healthcare safety and improves treatment results for those battling cancer. As an example, data from the World Health Organization (WHO), a Switzerland-based international agency, suggests that by 2050, cancer cases are predicted to rise to over 35 million, marking a 77% increase from the anticipated 20 million cases for 2022, recorded in February 2024. This striking increase underlines the intensifying global cancer burden. Additionally, the US-based National Center for Biotechnology Information announced in January 2023, that the US would see 1,958,310 novel cancer cases, with anticipated cancer deaths reaching 609,820 within that year. Consequently, the escalation in cancer cases fuels the growth of the closed system transfer devices market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

How Is the Closed System Transfer Devices Market Segmented by Several Divisions?

The closed system transfer devices market covered in this report is segmented –

1) By Type: Needleless Systems, Membrane-To-Membrane Systems

2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

Subsegments:

1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

What are the Emerging Market Trends Driving the Growth of the Closed System Transfer Devices Industry?

Leading businesses in the closed system transfer devices (CSTD) sector are prioritizing the creation of innovative syringe units to boost safety, elevate user experience, minimize contamination risks, and adhere to the stringent regulatory guidelines in the health care industry. A full volume use syringe is a type of syringe designed to dispense or administer the entire quantity of liquid or medicine contained, eliminating the necessity for extra mixing or dilution. For example, in October 2023, Equashield, a medical device firm based in the United States, introduced the EQUASHIELD Syringe Unit. This unit has received FDA approval and is specifically designed for full-volume use, thus making the handling of dangerous drugs safer and more efficient. Its unique design stops vapour leakage and plunger contamination, thereby providing an affordable solution for drug compounding and administration.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

Which Regions Are Driving Growth in the Closed System Transfer Devices Market?

North America was the largest region in the closed system transfer device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15767

This Report Delivers Insight On:

1. How big is the closed system transfer devices market, and how is it changing globally?

2. Who are the major companies in the closed system transfer devices market, and how are they performing?

3. What are the key opportunities and risks in the closed system transfer devices market right now?

4. Which products or customer segments are growing the most in the closed system transfer devices market?

5. What factors are helping or slowing down the growth of the closed system transfer devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the closed system transfer devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Closed System Transfer Devices Market Size from 2025 to 2034?

In recent times, there has been a significant growth in the market size of closed system transfer devices. This market is forecasted to expand from $1.04 billion in 2024 to $1.19 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.5%. This growth during the historical period can be credited to the rise in approvals for oncology drugs, increasing emphasis on job safety, the urgent need to reduce needlestick injuries and exposure to dangerous drugs, enhanced consciousness about the potential risks associated with exposure to cytotoxic drugs, and a surge in the population of chemotherapy patients.

In the upcoming years, the market size of closed system transfer devices is anticipated to experience a fast growth. By 2029, it is estimated to rise to $2.03 billion, boasting a compound annual growth rate (CAGR) of 14.3%. Factors such as the escalating incidence of cancer, the mounting necessity for compliance monitoring for safe handling of harmful drugs, growing consciousness about the usage of closed system transfer devices, the increased adoption of CSTDS for handling risky medications, and a higher number of cancer drug sanctions can account for this expected growth. Future trends include the launch of new products and an emphasis on safety, the creation of user-friendly devices and digital platforms, high levels of research and development, advances in technology, and a shift towards membrane-to-membrane systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Closed System Transfer Devices Market?

As cancer rates continue to rise, the demand for closed-system transfer devices in the medical market is expected to increase, directly propelling its market growth. Notably, cancer, a condition distinguished by uncontrolled abnormal cell growth that infringes upon neighboring tissues and spreads throughout the body via the blood and lymph systems, is being increasingly observed. Triggers for such prevalence can include lifestyle choices, environmental influences, and a spike in infections. Closed-system transfer devices play a pivotal role in cancer treatment by acting as a protective barrier for both healthcare practitioners and patients against risks while dealing with chemotherapy drugs. Consequently, they promote a safer medical environment and enhance treatment outcomes for cancer patients. For instance, the World Health Organization, a Swiss-based international organization, predicts that by 2050, we can anticipate cancer instances to surpass 35 million, marking a 77% surge from the estimated 20 million cases forecasted for 2022. This stark increase only amplifies the growing global cancer burden. According to the National Center for Biotechnology Information, a US-based international organization, 1,958,310 new cancer cases and an expected 609,820 cancer-related deaths were reported in the US alone in 2023. Hence, the escalating number of cancer cases fuels the expansion of the closed system transfer devices market.

Which Key Market Segments Comprise the Closed System Transfer Devices Market and Drive Its Revenue Growth?

The closed system transfer devices market covered in this report is segmented –

1) By Type: Needleless Systems, Membrane-To-Membrane Systems

2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

Subsegments:

1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

Which Areas Are Leading Regions in the Closed System Transfer Devices Market Expansion Across the Globe?

North America was the largest region in the closed system transfer device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Trends Are Shaping the Future of the Closed System Transfer Devices Market?

Leading firms in the closed system transfer devices (CSTD) market are prioritising the development of innovative syringe units to boost safety, augment user convenience, minimise contamination risk, and meet tight health industry regulations. A syringe developed for full volume use is one intended to deliver or administer the entirety of a fluid or drug, with no extra dilution or mixing required. For instance, in October 2023, the US-based medical equipment firm, Equashield, introduced the EQUASHIELD Syringe Unit, which secured FDA approval for full-volume usage, enabling safer and more effective handling of hazardous medications. This revolutionary design stops the escape of vapours and contamination of the plunger, making it an economical solution for compounding and administering drugs.

View the full report here:

https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

How Is the Closed System Transfer Devices Market Conceptually Defined?

Closed system transfer devices (CSTDs) are specialized drug transfer devices designed to mechanically prevent environmental contaminants from entering the system and to stop hazardous drugs or vapor concentrations from escaping. These devices create a closed, leak-proof system to ensure the safe handling of hazardous substances in healthcare environments.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15767

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Closed System Transfer Devices Market?

The escalating prevalence of cancer is set to fuel the expansion of the closed-system transfer devices market. Cancer, the unbridled multiplication of abnormal cells that potentially invade adjacent tissues and metastasize to different parts of the body, is rising due to various reasons, inclusive of lifestyle choices, environmental exposures, and higher infection rates. Closed-system transfer devices play a vital role in tackling cancer, ensuring safety among healthcare professionals and patients while handling and administering chemotherapy medications. This results in a secure healthcare setting and improved treatment outcomes for those suffering from cancer. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, declared in February 2024 that projected cancer cases would surge by 77% to over 35 million by 2050, from an anticipated 20 million cases in 2022. This underscores the growing global impact of cancer. Moreover, according to the US-based National Center for Biotechnology Information in January 2023, projections were made for 1,958,310 new cancer cases and 609,820 cancer deaths to occur in the US alone in 2023. The rising rate of cancer occurrences is therefore spurring the growth of the closed-system transfer devices market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

#What is the Projected CAGR for the Closed System Transfer Devices Market Size from 2025 to 2034?

The market size of closed system transfer devices has seen speedy advancement in the last few years. Its growth is expected to climb from $1.04 billion in 2024 to $1.19 billion in 2025, showcasing a compound annual growth rate (CAGR) of 14.5%. The historic period’s growth can be credited to factors such as the spike in oncological drug approvals, heightened focus on workplace safety and the escalating need to mitigate needlestick injuries and hazardous drug exposure. The increased cognizance about the possible risks of exposure to cytotoxic drugs and the rise in the chemotherapy patient community further fuel this growth.

The market size for closed system transfer devices is predicted to experience swift expansion in the upcoming years, reaching a size of $2.03 billion in 2029 with a compound annual growth rate (CAGR) of 14.3%. Factors contributing to this projected growth during the forecast period include an increase in cancer rates, heightened necessity for compliant monitoring to safely handle harmful drugs, growing recognition of the benefits of closed system transfer devices, increased use of CSTDS for the transportation of hazardous medications, and a rising number of approved drugs for cancer treatment. Key trends anticipated during the forecast period encompass fresh product introductions and safety measures, the creation of digital platforms and user-friendly devices, heightened activity in research and development, technological progress, and the adoption of membrane-to-membrane systems.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15767

What Are the Key Market Innovations in theClosed System Transfer Devices Market Over the Coming Years?

Key players within the closed system transfer devices (CSTD) market, like Equashield, are making strides in the innovation of syringe units, aiming to enhance safety protocols, maximize user comfort, attenuate contamination risks, and meet tough healthcare industry regulations. The concept of a syringe unit for full volume use refers to a uniquely designed syringe that can deliver or dispense an entire volume of a contained liquid or medication without any additional need to mix or dilute it. To illustrate this, in October 2023, Equashield, a household name in the American medical device market, rolled out its EQUASHIELD Syringe Unit. Receiving FDA approval for full-volume usage, this new design facilitates safer and more effective management of hazardous drugs. This innovative syringe prevents vapour from leaking and avoids plunger contamination, making it a financially smart solution for compounding and dispensing medications.

Who Are the Top Companies Driving Innovation and Growth in theClosed System Transfer Devices Market?

Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., Corning Incorporated, B Braun Melsungen AG, Grifols SA, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Carmel Pharma AB, Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

Which Key Market Segments Comprise the Closed System Transfer Devices Market and Drive Its Revenue Growth?

The closed system transfer devices market covered in this report is segmented –

1) By Type: Needleless Systems, Membrane-To-Membrane Systems

2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

Subsegments:

1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15767&type=smp

Which Regions Are Emerging as Leaders in the Closed System Transfer Devices Market?

North America was the largest region in the closed system transfer device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Closed System Transfer Devices Market 2025, By The Business Research Company:

Orthopedic Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Computer Storage Devices And Servers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/computer-storage-devices-and-servers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the closed system transfer devices market right now?

The closed system transfer devices market has experienced rapid growth in recent years. It will grow from $1.04 billion in 2024 to $1.19 billion in 2025, at a compound annual growth rate (CAGR) of 14.5%. This growth is due to the rising number of oncology drug approvals, increased focus on occupational safety, the need to reduce needlestick injuries and exposure to hazardous drugs, greater awareness of the dangers of cytotoxic drug exposure, and a growing chemotherapy patient population.

How fast Is the closed system transfer devices market expected to grow, and what’s its future value?

The closed system transfer devices market is projected to reach $2.03 billion by 2029 at a 14.3% CAGR. Growth is driven by the increasing occurrence of cancer, need for safe management of drugs, and the rise in drug sanctions for cancer. Trends include product launches, safety features, and membrane-to-membrane systems.

Get your closed system transfer devices market report here!

https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

What are the leading drivers of growth in the closed system transfer devices market?

The increasing occurrence of cancer is projected to boost the growth of the closed-system transfer devices market. Cancer, a condition marked by abnormal cell growth, is rising due to lifestyle, environmental factors, and infections. Closed-system transfer devices are essential for safely handling and administering chemotherapy drugs, protecting both healthcare workers and patients. In February 2024, the World Health Organization forecasted that global cancer cases would exceed 35 million by 2050, a 77% increase from 2022. This surge in cancer cases is expected to drive the demand for closed-system transfer devices.

What are the key segments defining the closed system transfer devices market?

The closed system transfer devices market covered in this report is segmented –

1) By Type: Needleless Systems, Membrane-To-Membrane Systems

2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

Subsegments:

1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

Who are the key players steering the development of the closed system transfer devices market?

Major companies operating in the closed system transfer devices market are Cardinal Health Inc., Becton Dickinson and Company, Baxter International Inc., Corning Incorporated, B Braun Melsungen AG, Grifols SA, Terumo Corporation, ICU Medical Inc., Amsino International Inc., JMS Co. Ltd., Vygon SA, Codan Medical GmbH, Equashield LLC, Hospira Inc., Nipro Corporation, Simplivia Healthcare Ltd., Practivet Inc., Corvida Medical Inc., Yukon Medical, Caragen Ltd., Insung Medical Co. Ltd., Carmel Pharma AB, Aegis Medical Technologies, Epic Medical Pte Ltd., Smiths Medical

What emerging trends are influencing the growth of the closed system transfer devices market?

Leading companies in the closed system transfer devices (CSTD) market are focusing on creating advanced syringe units to improve safety, enhance user experience, reduce contamination risks, and comply with strict healthcare regulations. A syringe unit for full volume use is designed to deliver the entire amount of medication or liquid without requiring mixing or dilution. For example, in October 2023, Equashield, a US-based medical device company, introduced the EQUASHIELD Syringe Unit, which received FDA approval for full-volume use. This design ensures safer handling of hazardous drugs, preventing vapor escape and plunger contamination, making it an affordable solution for compounding and administering medications.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15767

Which regions are most influential in expanding the closed system transfer devices market?

North America was the largest region in the closed system transfer device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Orthopedic Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Computer Storage Devices And Servers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/computer-storage-devices-and-servers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Future CAGR is Anticipated for the Closed System Transfer Devices Market Over the 2025–2034 Period?

The market size of closed system transfer devices has experienced significant expansion in the past few years. The industry, which was valued at $1.04 billion in 2024, is projected to rise to $1.19 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.5%. Factors contributing to the historical growth include the surge in oncology drug approvals, heightened attention towards occupational safety, a growing need to prevent needle-stick injuries and contact with dangerous drugs, amplified awareness of the risks associated with exposure to cytotoxic drugs, and an increase in the chemotherapy patient population.

The market for closed system transfer devices is set to experience significant expansion in the upcoming years, with an anticipated growth to $2.03 billion in 2029, indicating a compound annual growth rate (CAGR) of 14.3%. Factors contributing to this projected growth during the forecast period include the rising prevalence of cancer, the heightened need for compliance monitoring to ensure safe handling of harmful medications, increased awareness of closed system transfer devices, the growing use of CSTDS for delivering hazardous drugs, and the increasing number of drug approvals related to cancer. The key trends anticipated in the future encompass launch of new products and heightened focus on safety, creation of digital platforms and tools meant for user convenience, a surge in research and development efforts, technological progress, and a growing reliance on membrane-to-membrane systems.

Which Primary Drivers Are Supporting the Continued Expansion of the Closed System Transfer Devices Market?

The closed-system transfer devices market is poised to grow due to the escalating prevalence of cancer, a condition marked by the anarchic multiplication of abnormal cells that can infiltrate adjacent tissues and metastasize through the circulatory and lymphatic systems. The surge in cancer occurrences can be attributed to several factors, including lifestyle conditions, environmental contaminants, and growing infection rates. Closed-system transfer devices play a critical role in cancer therapy as they safeguard healthcare professionals and patients from risks linked to chemotherapy drug handling and administration. Their utilization enhances healthcare safety and improves patient outcomes in cancer treatment. For instance, data from the World Health Organization (WHO), a Switzerland-based intergovernmental body, in February 2024 predicts that by 2050, the number of cancer cases will soar to over 35 million, a 77% increase from the approximated 20 million cases anticipated for 2022. This considerable increase underscores the escalating cancer burden globally. Moreover, the National Center for Biotechnology Information, a US government body, reported in January 2023 that the number of new cancer cases in the US was 1,958,310 and projected cancer-related fatalities in 2023 to reach 609,820. Consequently, the escalating numbers of cancer cases are pushing the growth of the closed system transfer devices market.

Request Your Free Closed System Transfer Devices Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp

Who Are the Influential Players Fueling Innovation and Growth in the Closed System Transfer Devices Market?

Major companies operating in the closed system transfer devices market are:

• Cardinal Health Inc.

• Becton Dickinson and Company

• Baxter International Inc.

• Corning Incorporated

• B Braun Melsungen AG

What Impact Are Industry Trends Having on the Closed System Transfer Devices Market’s Future Prospects?

Firms that are major players in the closed system transfer devices (CSTD) market are now concentrating on creating innovative syringe units. The goal is to heighten safety, enhance the user experience, lower contamination risk and comply with rigorous regulatory rules within the healthcare sector. A syringe particularly designed to deliver or dispense the entire volume of liquid or medication it holds, without needing further mixing or dilution, is known as a full volume use syringe. An example of this would be Equashield, a US medical device firm, that in October 2023, launched the EQUASHIELD Syringe Unit. This unit has been given FDA approval for full-volume use, offering a safer and more efficient way to handle dangerous drugs. This cutting-edge design stops vapour leakage and prevents plunger contamination, making it a cost-effective solution for compounding and administering medications.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/closed-system-transfer-devices-global-market-report

Which Industry Segments Are Leading the Development and Expansion of the Closed System Transfer Devices Market?

The closed system transfer devices market covered in this report is segmented –

1) By Type: Needleless Systems, Membrane-To-Membrane Systems

2) By Technology: Diaphragm-Based, Compartmentalized, Filtration

3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems

4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users

Subsegments:

1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters

2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices

What Regions Are Leading the Growth Trajectory of the Closed System Transfer Devices Market?

North America was the largest region in the closed system transfer device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Defining Aspects of the Closed System Transfer Devices Market Landscape?

Closed system transfer devices (CSTDs) are specialized drug transfer devices designed to mechanically prevent environmental contaminants from entering the system and to stop hazardous drugs or vapor concentrations from escaping. These devices create a closed, leak-proof system to ensure the safe handling of hazardous substances in healthcare environments.

Browse Through More Similar Reports By The Business Research Company:

Orthopedic Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report

Cardiovascular Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Computer Storage Devices And Servers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/computer-storage-devices-and-servers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: